CDMO Selection
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
Scorpius BioManufacturing
PAO-11-23-CL-04Dec 08, 2023
Industry Wisdom
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
Pharma's Almanac
PAO-09-23-RT-02Sep 15, 2023
CDMO Selection
Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM197
Scorpius BioManufacturing
PR-M07-23-02Jul 27, 2023
Quality Culture
Does Your Biologics CDMO Truly Have a Culture of Quality?
Joe Payne
Scorpius BioManufacturing
PAO-07-23-CL-07Jul 27, 2023
Roundtable: Patient Centricity
How is an increased focus on patient-centric concerns influencing the way that you work?
Pharma's Almanac
PAO-07-23-RT-02Jul 21, 2023
Biomanufacturing
Biologics Outsourcing: Decision Drivers and Key Considerations
Scorpius BioManufacturing
PAO-04-23-CL-01Apr 18, 2023
Biomanufacturing
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
Scorpius BioManufacturing
PAO-01-23-CL-04Jan 31, 2023
Biomanufacturing
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
Scorpius BioManufacturing
PR-M12-22-02Dec 21, 2022
Bioanalytics
ABC: Analytics for Biomanufacturing and Clinical Trials of Biomanufactured Products
Samir Lakhashe, Ph.D.
Scorpius BioManufacturing
PAO-10-21-CL-08Oct 15, 2021